Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Waninger

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
JAMA Network Open|March 9, 2021
Validation of the American Joint Committee on Cancer Eighth Edition Staging of Patients With Metastatic Cutaneous Melanoma Treated With Immune Checkpoint InhibitorsJessica J Waninger, Vincent T Ma, Sara Journey, et al.
PNAS Nexus|August 4, 2022
Argonaute 2 modulates EGFR-RAS signaling to promote mutant <i>HRAS</i> and <i>NRAS-</i>driven malignanciesRonald F Siebenaler, Seema Chugh, Jessica J Waninger, et al.
Cancer Cell|January 13, 2023
Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapyGaopeng Li, Jae Eun Choi, Ilona Kryczek, et al.
Nature Medicine|January 5, 2021
Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell eliminationJiali Yu, Michael D Green, Shasha Li, et al.
Cancer Cell|June 11, 2021
Tim-4<sup>+</sup> cavity-resident macrophages impair anti-tumor CD8<sup>+</sup> T cell immunityAndrew Chow, Sara Schad, Michael D Green, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
JAMA Network Open|March 9, 2021
Validation of the American Joint Committee on Cancer Eighth Edition Staging of Patients With Metastatic Cutaneous Melanoma Treated With Immune Checkpoint InhibitorsJessica J Waninger, Vincent T Ma, Sara Journey, et al.
PNAS Nexus|August 4, 2022
Argonaute 2 modulates EGFR-RAS signaling to promote mutant <i>HRAS</i> and <i>NRAS-</i>driven malignanciesRonald F Siebenaler, Seema Chugh, Jessica J Waninger, et al.
Cancer Cell|January 13, 2023
Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapyGaopeng Li, Jae Eun Choi, Ilona Kryczek, et al.
Nature Medicine|January 5, 2021
Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell eliminationJiali Yu, Michael D Green, Shasha Li, et al.
Cancer Cell|June 11, 2021
Tim-4<sup>+</sup> cavity-resident macrophages impair anti-tumor CD8<sup>+</sup> T cell immunityAndrew Chow, Sara Schad, Michael D Green, et al.
Pageof 6